Department of Epidemiology, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
J Gerontol A Biol Sci Med Sci. 2021 Oct 13;76(11):2062-2070. doi: 10.1093/gerona/glab221.
To investigate the influence of diabetes duration and glycemic control, assessed by glycated hemoglobin (HbA1c) levels, on risk of incident dementia.
The present study is a prospective study of 461 563 participants from the UK Biobank. The age at diabetes diagnosis was determined by self-report. Diabetes duration was calculated as baseline age minus age at diagnosis. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) with 95% confidential intervals (CIs).
During a median follow-up of 8.1 years, 2 233 dementia cases were recorded. As compared with normoglycemic individuals, individuals with diabetes had higher risk of all-cause dementia, and the risk increased with increasing duration of diabetes; compared with participants with diabetes duration of <5 years, the multivariable-adjusted HRs (95% CIs) were 1.49 (1.12-1.97), 1.71 (1.21-2.41), and 2.15 (1.60-2.90) for those with diabetes durations ≥5 to < 10, ≥10 to <15, and ≥ 15 years, respectively (p for trend < .001). Among participants with diabetes, those with both longer diabetes duration (diabetes duration ≥ 10 years) and poor glycemic control (HbA1c ≥ 8%) had the highest risk of all-cause dementia (multivariable-adjusted HR = 2.07, 95% CI 1.45, 2.94), compared with patients with shorter duration of diabetes and better glycemic control (diabetes duration < 10 years and HbA1c < 8%).
Diabetes duration appeared to be associated with the risk of incident dementia due to factors beyond glycemic control. Clinicians should consider not only glycemic control but also diabetes duration in dementia risk assessments for patients with diabetes.
本研究旨在探讨糖尿病病程(通过糖化血红蛋白[HbA1c]水平评估)和血糖控制对新发痴呆风险的影响。
本研究是一项针对英国生物银行 461563 名参与者的前瞻性研究。糖尿病诊断年龄通过自我报告确定。糖尿病病程的计算方法为基线年龄减去诊断年龄。采用 Cox 比例风险回归模型估计风险比(HR)及其 95%置信区间(CI)。
在中位随访 8.1 年期间,记录到 2233 例痴呆病例。与血糖正常者相比,糖尿病患者发生全因痴呆的风险更高,且随着糖尿病病程的延长而增加;与病程<5 年的参与者相比,病程≥5 年但<10 年、≥10 年但<15 年、≥15 年的多变量校正 HR(95%CI)分别为 1.49(1.12-1.97)、1.71(1.21-2.41)和 2.15(1.60-2.90)(趋势检验 p<0.001)。在患有糖尿病的参与者中,病程较长(糖尿病病程≥10 年)且血糖控制不佳(HbA1c≥8%)的患者发生全因痴呆的风险最高(多变量校正 HR=2.07,95%CI 1.45-2.94),与病程较短且血糖控制较好的患者(糖尿病病程<10 年且 HbA1c<8%)相比。
糖尿病病程与血糖控制以外的因素相关,可能与新发痴呆风险相关。临床医生在评估糖尿病患者的痴呆风险时,不仅应考虑血糖控制,还应考虑糖尿病病程。